TOL-463 Phase 2 Study for Vaginitis

NCT02866227 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Vaginosis
Vulvovaginal Candidiasis

Interventions

DRUG: TOL-463
DRUG: TOL-463

Sponsor

Toltec Pharmaceuticals, LLC